Follow on Google News
News By Tag
News By Place
Follow on Google News
FDA Warns Of Acetaminophen Dangers
Ennis & Ennis, P.A. reports that the Food and Drug Administration (FDA) issued a safety warning to healthcare professionals advising them that acetaminophen has been associated with risks of rare but serious, even fatal skin reactions.
The FDA reviewed a compilation of its Adverse Event Reports and the medical literature available to evaluate the cases of severe skin reactions associated with acetaminophen. The FDA noted that it is difficult to assess how frequently serious skin reactions occur due to the widespread use of the drug, the length of time on the market and differences in use among individuals. However, it is believed that conditions such as SJS, TENS and AGEP rarely occur.
The severe skin reactions are such a concern, however that the FDA notified healthcare professional of this risk and to consider acetaminophen when assessing patients with potentially drug induced skin reactions. The FDA will now require a warning be added to the labels of prescription drug products containing acetaminophen to address the risk of serious skin reactions. The FDA will also request, but not require at this time, manufacturers of OTC medications containing acetaminophen to add a warning regarding serious skin reactions. Any patient who develops any type of skin rash or reaction while using acetaminophen should stop the drug and seek medical attention right away. Further, anyone who has experience a serious skin reaction while using acetaminophen should never take the drug again and seek alternative pain relievers.
Ennis & Ennis, P.A. continues to offer free, nationwide, confidential consultations to anyone who suffered an injury from acetaminophen by calling toll free 1-800-856-6405 or by going to www.ennislaw.com and completing an online case evaluation form. Ennis & Ennis, P.A. is a nationwide law firm with offices in Ft. Lauderdale, Miami and Washington D.C. that concentrates its practice in mass torts and represents individuals against pharmaceutical companies and medical device makers.